BPC-157 — formally designated Body Protection Compound 157 — is a synthetic pentadecapeptide comprising 15 amino acids. Its sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is derived from a portion of Body Protection Compound (BPC), a protein naturally isolated from human gastric juice. Since its characterization in the early 1990s, BPC-157 has been the subject of extensive in-vitro and in-vivo research across multiple scientific disciplines.
This article provides a comprehensive overview of BPC-157 for researchers, covering its biochemical identity, proposed mechanisms of action, documented findings from laboratory studies, storage and handling requirements, and the critical importance of purity verification when sourcing this compound for scientific use.
Biochemical Identity & Structural Properties
BPC-157 is a 15-amino-acid peptide with the molecular formula C62H98N16O22 and a molecular weight of approximately 1,419.5 g/mol. Unlike many naturally occurring peptides, BPC-157 is noted for its exceptional stability in aqueous environments — including simulated gastric fluid — compared to its parent compound BPC, which degrades rapidly in the same conditions.
Its sequence features a proline-rich region (Pro-Pro-Pro) that is believed to confer structural rigidity and resistance to proteolytic degradation. This stability profile makes it a particularly tractable candidate for in-vitro assay design, as researchers can maintain consistent compound concentrations across longer experimental timeframes without the rapid degradation seen in less stable peptides.
| Property | Value |
|---|---|
| Full Name | Body Protection Compound 157 |
| Amino Acid Length | 15 residues |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | ~1,419.5 g/mol |
| CAS Number | 137525-51-0 |
| Solubility | Water-soluble (acetic acid may enhance solubility) |
| Storage Recommendation | Lyophilized: −20°C; Reconstituted: 2–8°C, use within 2 weeks |
Proposed Mechanisms of Action in Research Models
BPC-157's observed effects in research models are attributed to several interacting biological pathways. Below, we outline the primary mechanisms identified in the published literature.
Nitric Oxide (NO) Pathway Modulation
Multiple studies have reported BPC-157's involvement in the nitric oxide (NO) system. Research in rodent models has documented upregulation of eNOS (endothelial nitric oxide synthase) activity following BPC-157 administration. Nitric oxide plays a central role in vascular tone, cellular signaling, and angiogenic processes, positioning this mechanism as a key area of interest for researchers studying vascular biology and tissue modeling in vitro.
Angiogenic Signaling
BPC-157 has been observed to upregulate VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) expression in research models. This receptor plays a pivotal role in angiogenesis — the formation of new blood vessel networks from existing vasculature. In cell culture settings, researchers have explored how BPC-157 influences endothelial cell migration and tube formation assays, making it a compound of interest in wound-healing and vascular biology research platforms.
Growth Factor Expression
Laboratory studies have reported BPC-157's interaction with the Egr-1 transcription factor pathway and modulation of growth hormone receptor expression in certain tissue models. Egr-1 regulates the transcription of numerous growth-related genes, and its study in conjunction with BPC-157 has formed the basis of several published in-vitro investigations into cell proliferation signaling.
FAK-Paxillin Pathway & Cell Migration
Research has documented BPC-157's apparent influence on the Focal Adhesion Kinase (FAK) — paxillin signaling axis. FAK is a critical mediator of integrin-dependent cell adhesion, migration, and survival signaling. In fibroblast and smooth muscle cell research models, BPC-157 exposure has been associated with altered paxillin phosphorylation states and changes in cytoskeletal organization — findings that have driven interest in its use as a research tool in studies of cell motility and tissue remodeling.
Overview of Research Findings
The peer-reviewed literature on BPC-157 spans several decades and covers a wide range of research model types. The following summary reflects findings reported in published preclinical studies and is presented solely to contextualize the compound's research utility:
- Gastrointestinal cell models: BPC-157 has been studied extensively in GI-focused cell cultures, where researchers have examined its influence on epithelial cell viability and barrier function assays.
- Musculoskeletal tissue research: Tendon-derived fibroblast cultures have been used to study BPC-157's effects on collagen gene expression and cell proliferation rates.
- Vascular endothelial assays: Tube formation and scratch-wound assays with HUVEC (Human Umbilical Vein Endothelial Cells) have been used to examine BPC-157's influence on angiogenic behavior in vitro.
- CNS-adjacent research: Some published work has examined BPC-157's interactions with dopaminergic and serotonergic signaling components in neuronal cell models, representing an emerging area of in-vitro investigation.
Why Purity Matters in BPC-157 Research
For researchers working with BPC-157, compound purity is not a peripheral concern — it is foundational to the validity of any experimental outcome. Here's why:
Contaminants Confound Results
A peptide sample with 90% purity contains 10% unknown material. That 10% may include truncated sequences (deletion peptides), oxidized amino acid residues, acetylation byproducts, or residual synthesis solvents. In a sensitive cell-based assay, these contaminants can produce off-target effects that are indistinguishable from the compound's actual activity — rendering the data scientifically meaningless or worse, misleading.
Batch-to-Batch Consistency
Reproducibility is the cornerstone of scientific research. If two batches of BPC-157 from the same supplier vary in purity from 92% to 98%, a researcher attempting to replicate their own experiment — or another group's published work — is working with meaningfully different compounds. This is why COA batch verification is an essential part of any rigorous peptide research protocol.
HPLC Purity vs. Mass Spec Confirmation
HPLC purity (expressed as a percentage of the main peak area at a specific UV wavelength, typically 220nm) tells you how much of the sample is the primary compound relative to all UV-absorbing material. Mass spectrometry (MS) confirmation tells you that the compound has the correct molecular weight — confirming identity. Both tests together are necessary. A sample can show high HPLC purity while still being the wrong compound if only HPLC is used without MS verification. Always request both when sourcing research-grade peptides.
Storage & Handling Guidelines
Proper storage of BPC-157 is essential for maintaining compound integrity throughout the research process:
- Lyophilized powder: Store at −20°C in a desiccated, light-protected environment. Under these conditions, lyophilized BPC-157 remains stable for extended periods (typically 24+ months from manufacture date).
- Reconstitution: Use sterile bacteriostatic water or 0.9% saline. For particularly low-solubility batches, a small amount of dilute acetic acid (0.1%) may be used to aid dissolution before diluting to working concentration with aqueous buffer.
- Post-reconstitution: Store at 2–8°C. Use within 14 days. Avoid repeated freeze-thaw cycles, which can degrade peptide structure and introduce aggregation.
- Handling: Use low-protein-binding tubes and pipette tips to minimize adsorption losses, particularly at low working concentrations.
Sourcing Considerations for Researchers
The peptide research market varies considerably in quality standards. When evaluating a BPC-157 supplier, researchers should require the following as a minimum standard:
- HPLC purity ≥ 98% (we provide ≥ 99%)
- Mass spectrometry (MS) identity confirmation linked to the specific batch number
- Third-party (independent laboratory) testing — not in-house only
- Batch-specific COA available before or at time of order
- Clear lyophilization documentation and storage conditions
At QuantisPeptides, in partnership with Golden Lotus Labs, every batch of BPC-157 we supply comes with a complete third-party COA tied to its unique batch number. Purity is verified at ≥ 99% by HPLC, with mass spectrometry identity confirmation included as standard. We believe transparency in batch documentation is not optional — it's a basic obligation to the research community.
